Wall Street Journal. Europe 2001 Carolyn Whelan - Abstracts
| Wall Street Journal. Europe 2001 Carolyn Whelan | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Analysts expect surge in profit for Aventis; gain of about 40% seen for first nine months. | Business, international | Carolyn Whelan | |||
| Aventis expects to meet or beat earnings target. | Business, international | Carolyn Whelan | |||
| Aventis posts 31% increase in net, raises its targets for full year.(2001) | Business, international | Carolyn Whelan | |||
| Fund infusion in France helps biotech industry. | Business, international | Carolyn Whelan | |||
| Lafarge, Saint-Gobain face threat from U.S. slowdown.(Investor haven from tech turmoil is at risk.) | Business, international | Carolyn Whelan | |||
| Sanofi exceeded forecasts as profit jumped in 1st half.(2001) | Business, international | Carolyn Whelan | |||
| Suez 1st-half net increased 11% and sales climbed.(2001) | Business, international | Carolyn Whelan | |||
| Vinci's bid for TBI, though logical, may prove costly.(Vinci S.A.'s bid for TBI Group) | Business, international | Carolyn Whelan | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.